# Safety and Efficacy of ORM-12741 in Patients With Alzheimer's Disease

> **NCT01324518** · PHASE2 · COMPLETED · sponsor: **Orion Corporation, Orion Pharma** · enrollment: 100 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** ORM-12741
- **DRUG:** ORM-12741
- **DRUG:** Placebo for ORM-12741

## Key facts

- **NCT ID:** NCT01324518
- **Lead sponsor:** Orion Corporation, Orion Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2012-09
- **Final completion:** 2012-10
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2021-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01324518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01324518, "Safety and Efficacy of ORM-12741 in Patients With Alzheimer's Disease". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01324518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*